Focus: Tenon Medical is a public medical device company focused on surgical solutions for chronic lower back pain, specifically sacroiliac joint disruption. The company operates at early-stage commercialization with $3M in annual revenue as of FY 2025.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
No open roles listed right now. Follow Tenon Medical to get notified when they start hiring — the background below is worth knowing for when they do.
Lead surgical device program targeting sacroiliac joint fusion, currently in early pipeline with 1 clinical trial.
Help build intelligence for Tenon Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Tenon Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT), Neurogene (NGNE) and ARS Pharmaceuticals (SPRY) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT), Neurogene (NGNE) and ARS Pharmaceuticals (SPRY) The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Tenon Medical, Inc. (TNON) - The Globe and Mail
Analysts Are Bullish on These Healthcare Stocks: Immunic (IMUX), Tenon Medical, Inc. (TNON) The Globe and Mail
Tenon(R) Medical Reports First Quarter 2026 Financial Results - ACCESS Newswire
Tenon(R) Medical Reports First Quarter 2026 Financial Results ACCESS Newswire
Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings - ACCESS Newswire
Tenon Medical, Inc. Sets Date for First Quarter 2026 Earnings ACCESS Newswire
Tenon Medical (TNON) Stock Dark Pool Prints (+0.51%) 2026-04-20 - Value Factor - thelegaladvocate.com
Tenon Medical (TNON) Stock Dark Pool Prints (+0.51%) 2026-04-20 - Value Factor thelegaladvocate.com
Tenon Medical (TNON) Stock Dark Pool Prints (+0.51%) 2026-04-20 - Buy Signals - Xã Thanh Hà
Tenon Medical (TNON) Stock Dark Pool Prints (+0.51%) 2026-04-20 - Buy Signals Xã Thanh Hà
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Recent peer-reviewed publications with author affiliations at this company
Twelve-month clinical and radiographic outcomes following inferior-posterior sacroiliac joint fusion using the Catamaran SI Joint Fusion System: a prospective, multi-center evaluation.
Catamaran SI Joint Fusion System((R)) MAINSAIL(TM) Study: a prospective, single-arm, multi-center, post-market study of six-month clinical outcomes and twelve-month radiographic findings.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo